ArticleMolecular therapy. Nucleic acids2018

A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma.

Kai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.